Overexpression of mtCYB was associated with increased tumor growth and invasion in vivo. Interestingly, inhibition of ROS inhibited cell proliferation driven by NF-κB, thus, suggesting that increase in ROS upon cytochrome b mutation is involved in mediating cell proliferation in bladder cancer [164]. Here, NFKB1 is linked to neoplasm.